Lung cancer is one of the leading causes of cancer death in USA and new studies continue to conduct to help patients in successfully recovering from the disease. According to a new…
Author: Lung Cancer
Lung Cancer Awareness Month: Getting Screened for Lung Cancer
November is the National Lung Cancer Month and aims at bringing awareness about this disease to the public. Recent studies have shown an increase in lung cancer mortality and decrease in lung…
Study Shows Treating Depression Could Lengthen Lung Cancer Survival
Depression is a common symptom that comes with patients suffering from lung cancer. During the journey from lung cancer diagnosis to its treatment, involves significant time and various treatment processes. Some patients…
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space mobility during lung cancer treatment. The study has been…
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is called as RATS which is…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…